146 related articles for article (PubMed ID: 19243745)
1. Does luteal estradiol supplementation have a role in long agonist cycles?
Elgindy EA; El-Haieg DO; Mostafa MI; Shafiek M
Fertil Steril; 2010 May; 93(7):2182-8. PubMed ID: 19243745
[TBL] [Abstract][Full Text] [Related]
2. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
3. Luteal supplementation in in vitro fertilization: more questions than answers.
Hubayter ZR; Muasher SJ
Fertil Steril; 2008 Apr; 89(4):749-58. PubMed ID: 18406833
[TBL] [Abstract][Full Text] [Related]
4. Degrees of uncertainty--"statistically insignificant".
Claman P
Fertil Steril; 2008 Oct; 90(4):1331; author reply 1331. PubMed ID: 18793767
[No Abstract] [Full Text] [Related]
5. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
Yıldız GA; Şükür YE; Ateş C; Aytaç R
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
[TBL] [Abstract][Full Text] [Related]
6. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.
Ghanem ME; Sadek EE; Elboghdady LA; Helal AS; Gamal A; Eldiasty A; Bakre NI; Houssen M
Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001
[TBL] [Abstract][Full Text] [Related]
7. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.
Lin H; Li Y; Li L; Wang W; Zhang Q; Chen X; Yang D
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):171-5. PubMed ID: 23287635
[TBL] [Abstract][Full Text] [Related]
8. Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach.
Garcia-Velasco JA; Motta L; López A; Mayoral M; Cerrillo M; Pacheco A
Fertil Steril; 2010 Dec; 94(7):2820-3. PubMed ID: 20673892
[TBL] [Abstract][Full Text] [Related]
9. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A
Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
[TBL] [Abstract][Full Text] [Related]
10. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2008 Apr; 89(4):789-92. PubMed ID: 18406835
[TBL] [Abstract][Full Text] [Related]
11. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
12. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles.
Lukaszuk K; Liss J; Lukaszuk M; Maj B
Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571
[TBL] [Abstract][Full Text] [Related]
13. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
Engmann L; DiLuigi A; Schmidt D; Benadiva C; Maier D; Nulsen J
Fertil Steril; 2008 Mar; 89(3):554-61. PubMed ID: 17678651
[TBL] [Abstract][Full Text] [Related]
14. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide.
Shastri SM; Barbieri E; Kligman I; Schoyer KD; Davis OK; Rosenwaks Z
Fertil Steril; 2011 Feb; 95(2):592-5. PubMed ID: 21074154
[TBL] [Abstract][Full Text] [Related]
17. Estradiol supplementation during the luteal phase of in vitro fertilization cycles: a prospective randomised study.
Tonguc E; Var T; Ozyer S; Citil A; Dogan M
Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):172-6. PubMed ID: 21067858
[TBL] [Abstract][Full Text] [Related]
18. Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for intrauterine insemination: need or habit?
Kyrou D; Fatemi HM; Tournaye H; Devroey P
Hum Reprod; 2010 Oct; 25(10):2501-6. PubMed ID: 20719809
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection.
Razieh DF; Maryam AR; Nasim T
Taiwan J Obstet Gynecol; 2009 Sep; 48(3):245-8. PubMed ID: 19797013
[TBL] [Abstract][Full Text] [Related]
20. Multiple-dose versus single-dose gonadotropin-releasing hormone agonist after first in vitro fertilization failure associated with luteal phase deficiency: A randomized controlled trial.
Qu D; Li Y
J Int Med Res; 2020 Jun; 48(6):300060520926026. PubMed ID: 32495663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
